# Sinclair Beats $3B-Backed Altos to the Clinic With First Human Epigenetic Reprogramming Trial - Date: 2026-04-04 - Category: Biotech & Life Sciences The FDA cleared the first human trial of partial epigenetic reprogramming. Life Biosciences, a tiny Boston startup co-founded by David Sinclair, beat $3B-backed Altos Labs to the clinic. A 30-year theory of aging is on the line. ---